Holoprosencephaly: a guide to diagnosis and clinical management

Manu S Raam1, Benjamin D Solomon, Maximilian Muenke

  • 1HHMI-NIH Research Scholars Program, Howard Hughes Medical Institute, Chevy Chase, MD, United States.

Indian Pediatrics
|July 12, 2011
PubMed

Insights

Holoprosencephaly, a common brain malformation, requires prompt diagnosis and management. Early recognition and genetic evaluation are crucial for affected Indian children to improve outcomes and understand recurrence risks.

Area of Science:

  • Neuroscience
  • Medical Genetics
  • Pediatrics

Background:

  • Holoprosencephaly (HPE) is the most common forebrain structural anomaly, affecting 1 in 8,000 births.
  • It causes facial dysmorphism, neurological deficits, and other complications.
  • HPE's genetic contribution to perinatal mortality in India highlights the need for improved recognition and management.

Purpose of the Study:

  • To review the diagnosis, management, and genetic aspects of holoprosencephaly.
  • To emphasize the importance of early identification and intervention for affected children in India.

Main Methods:

  • Literature search of the PubMed database using keywords: "holoprosencephaly," "HPE," and "holoprosencephaly India."
  • Cross-referencing identified articles and leveraging expert experience to select seminal papers.

Main Results:

  • Holoprosencephaly is classified into four types based on brain malformations and associated craniofacial phenotypes.
  • While genetic loci are identified, many causes remain unknown, with incomplete penetrance and variable expressivity posing challenges.
  • Neuroimaging and pathological examination are key for classification.

Conclusions:

  • Pediatricians should implement a diagnostic protocol including dysmorphology, family history, and neuroimaging.
  • Management should prioritize issues like hypothalamic/endocrinologic dysfunction, motor impairment, respiratory problems, seizures, and hydrocephalus.
  • Collaboration with genetic specialists for cytogenetic and molecular investigations, and genetic counseling is essential for prognosis and recurrence risk assessment.
Abstract